Mild Parkinsonian Signs in a Hospital-based Cohort of Mild Cognitive Impairment Types: A Cross-sectional Study
Journal:
Current Alzheimer Research
Volume:
16
Page:
633-649
Author(s):
Cecilia Camarda*, Paola Torelli, Carmela Pipia, Iacopo Battaglini, Delia Azzarello, Rosamaria Rosano, Caterina Claudia Ventimiglia, Gianluca Sottile, Giovanna Cilluffo and Rosolino Camarda
Nanoparticles: Properties and Applications in Cancer Immunotherapy
Journal:
Current Pharmaceutical Design
Volume:
25
Page:
1962-1979
Author(s):
Alessandra Iscaro*, Nutter F. Howard and Munitta Muthana*
Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design
Journal:
Current Alzheimer Research
Volume:
16
Page:
622-632
Author(s):
Fei Ma, Xuan Zhou, Qing Li, Jiangang Zhao, Aili Song, Peilin An, Yue Du, Weili Xu and Guowei Huang*
Current Genetic and Epigenetic Insights into Type 2 Diabetes Mellitus
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
19
Page:
717-718
Author(s):
Fahmida Alam, Mohammad A. Kamal, Md. Asiful Islam and Shaheena Banu
Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
19
Page:
845-851
Author(s):
Sahar Ahmed* and Rasha Sobh
Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
19
Page:
775-786
Author(s):
Tareq Hossan*, Shoumik Kundu, Sayeda Sadia Alam and Sankari Nagarajan
The Pleiotropic Effects of Statins in Endocrine Disorders
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
19
Page:
787-793
Author(s):
Javier A. De La Cruz, Christos G. Mihos, Sofia A. Horvath and Orlando Santana*
The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
19
Page:
719-731
Author(s):
Fatemeh Khatami, Mohammad R. Mohajeri-Tehrani and Seyed M. Tavangar*
Insights into the Role of DNA Methylation and Protein Misfolding in Diabetes Mellitus
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
19
Page:
744-753
Author(s):
Sara M. Ahmed, Dina Johar, Mohamed Medhat Ali and Nagwa El-Badri*
25 Hydroxyvitamin D Levels are Negatively and Independently Associated with Fat Mass in a Cohort of Healthy Overweight and Obese Subjects
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
19
Page:
838-844
Author(s):
Giovanni De Pergola*, Tommaso Martino, Roberta Zupo, Domenico Caccavo, Claudio Pecorella, Silvia Paradiso, Franco Silvestris and Vincenzo Triggiani